Listen to Kenneth Mulvany, CEO BenevolentAI discussing AI in Medicine at BBC Business Live
Professor Jackie Hunter, CEO, BenevolentBio, gave evidence at The House of Lords Science and Technology Select Committee
Listen to our founder Ken Mulvany discussing BenevolentAI's work on artificial intelligence applied to drug discovery.
Jérôme Pesenti introduces BenevolentAI's work on applying artificial intelligence to improve scientific discoveries
BenevolentAI team explains why the use of DGX-1 will help them in their daily work
by the team at BenevolentAI